p15PAF Is an Rb/E2F-Regulated S-Phase Protein Essential for DNA Synthesis and Cell Cycle Progression

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Chang, Chih Ning ^a   Feng, Mow Jung ^a   Chen, Yu Ling ^a   Yuan, Ray Hwang ^b   Jeng, Yung Ming ^a,b  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

NUCLEAR PROTEIN; PROTEIN P15 PAF; PROTEIN P21; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR E2F; TRANSCRIPTION FACTOR E2F4; TRANSCRIPTION FACTOR E2F6; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CELL PROLIFERATION; CONTROLLED STUDY; DNA SYNTHESIS; HUMAN; HUMAN CELL; HUMAN TISSUE; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN MOTIF; TRANSCRIPTION REGULATION; UPREGULATION;

BASE SEQUENCE; BINDING SITES; CARRIER PROTEINS; CELL CYCLE; CELL LINE; CHROMATIN; DNA REPLICATION; E2F TRANSCRIPTION FACTORS; GENE EXPRESSION; GENE KNOCKDOWN TECHNIQUES; HUMANS; NUCLEOTIDE MOTIFS; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; RETINOBLASTOMA PROTEIN; S PHASE; SIGNAL TRANSDUCTION;

EID: 84875945038     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0061196     Document Type: Article

References (24)

1. Yu P, Huang B, Shen M, Lau C, Chan E, et al. (2001) p15(PAF), a novel PCNA associated factor with increased expression in tumor tissues. Oncogene 20: 484-489.
2. Yuan RH, Jeng YM, Pan HW, Hu FC, Lai PL, et al. (2007) Overexpression of KIAA0101 predicts high stage, early tumor recurrence, and poor prognosis of hepatocellular carcinoma. Clin Cancer Res 13: 5368-5376.
3. Kato T, Daigo Y, Aragaki M, Ishikawa K, Sato M, et al. (2012) Overexpression of KIAA0101 predicts poor prognosis in primary lung cancer patients. Lung Cancer 75: 110-118.
4. Kais Z, Barsky SH, Mathsyaraja H, Zha A, Ransburgh DJ, et al. (2011) KIAA0101 interacts with BRCA1 and regulates centrosome number. Mol Cancer Res 9: 1091-1099.
5. Hosokawa M, Takehara A, Matsuda K, Eguchi H, Ohigashi H, et al. (2007) Oncogenic role of KIAA0101 interacting with proliferating cell nuclear antigen in pancreatic cancer. Cancer Res 67: 2568-2576.
6. Simpson F, Lammerts van Bueren K, Butterfield N, Bennetts JS, Bowles J, et al. (2006) The PCNA-associated factor KIAA0101/p15(PAF) binds the potential tumor suppressor product p33ING1b. Exp Cell Res 312: 73-85.
7. Cheung KJ Jr, Mitchell D, Lin P, Li G, (2001) The tumor suppressor candidate p33(ING1) mediates repair of UV-damaged DNA. Cancer Res 61: 4974-4977.
8. Turchi L, Fareh M, Aberdam E, Kitajima S, Simpson F, et al. (2009) ATF3 and p15PAF are novel gatekeepers of genomic integrity upon UV stress. Cell Death Differ 16: 728-737.
9. Kais Z, Barsky SH, Mathsyaraja H, Zha A, Ransburgh DJ, et al. (2011) KIAA0101 interacts with BRCA1 and regulates centrosome number. Mol Cancer Res 9: 1091-1099.
10. Strzalka W, Ziemienowicz A, (2011) Proliferating cell nuclear antigen (PCNA): a key factor in DNA replication and cell cycle regulation. Ann Bot 107: 1127-1140.
11. Waga S, Hannon GJ, Beach D, Stillman B, (1994) The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature 369: 574-578.
12. DeGregori J, Kowalik T, Nevins JR, (1995) Cellular targets for activation by the E2F1 transcription factor include DNA synthesis- and G1/S-regulatory genes. Mol Cell Biol 15: 4215-4224.
13. Münger K, Basile JR, Duensing S, Eichten A, Gonzalez SL, et al. (2001) Biological activities and molecular targets of the human papillomavirus E7 oncoprotein. Oncogene 20: 7888-7898.
14. Liao CC, Tsai CY, Chang WC, Lee WH, Wang JM, (2010) RB·E2F1 complex mediates DNA damage responses through transcriptional regulation of ZBRK1. J Biol Chem 285: 33134-33143.
15. Croxton R, Ma Y, Song L, Haura EB, Cress WD, (2002) Direct repression of the Mcl-1 promoter by E2F1. Oncogene 21: 1359-1369.
16. Giacinti C, Giordano A, (2006) RB and cell cycle progression. Oncogene 25: 5220-5227.
17. Jain M, Zhang L, Patterson EE, Kebebew E, (2011) KIAA0101 is overexpressed, and promotes growth and invasion in adrenal cancer. PLoS One 6: e26866.
18. Mizutani K, Onda M, Asaka S, Akaishi J, Miyamoto S, et al. (2005) Overexpressed in anaplastic thyroid carcinoma-1 (OEATC-1) as a novel gene responsible for anaplastic thyroid carcinoma. Cancer 103: 1785-1790.
19. Emanuele MJ, Ciccia A, Elia AE, Elledge SJ, (2011) Proliferating cell nuclear antigen (PCNA)-associated KIAA0101/PAF15 protein is a cell cycle-regulated anaphase-promoting complex/cyclosome substrate. Proc Natl Acad Sci U S A 108: 9845-9850.
20. Gartel AL, Serfas MS, Tyner AL, (1996) p21--negative regulator of the cell cycle. Proc Soc Exp Biol Med 213: 138-149.
21. Yu P, Huang B, Shen M, Lau C, Chan E, et al. (2001) p15(PAF), a novel PCNA associated factor with increased expression in tumor tissues. Oncogene 20: 484-489.
22. Egelkrout EM, Mariconti L, Settlage SB, Cella R, Robertson D, (2002) Two E2F elements regulate the proliferating cell nuclear antigen promoter differently during leaf development. Plant Cell 14: 3225-3236.
23. Hateboer G, Wobst A, Petersen BO, Le Cam L, Vigo E, et al. (1998) Cell cycle-regulated expression of mammalian CDC6 is dependent on E2F. Mol Cell Biol 18: 6679-6697.
24. Burkhart DL, Wirt SE, Zmoos AF, Kareta MS, Sage J, (2010) Tandem E2F binding sites in the promoter of the p107 cell cycle regulator control p107 expression and its cellular functions. PLoS Genet 6: e1001003.